Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration

被引:31
作者
Cardigan, RA
McGloin, H
Mackie, IJ
Machin, SJ
Singer, M
机构
[1] UCL, Sch Med, Dept Haematol, London W1N 8AA, England
[2] UCL, Sch Med, Bloomsbury Inst Intens Care Med, London W1N 8AA, England
关键词
continuous venovenous hemofiltration; thrombin; blood flow; dialysis; anticoagulation; tissue factor;
D O I
10.1046/j.1523-1755.1999.00397.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration (CVVH). Despite adequate exogenous anticoagulation, the occlusion of CVVH circuits can occur within minutes to a few hours of use and is associated with evidence of thrombin generation. Having found no evidence of activation of the contact factor (intrinsic coagulation) pathway during CVVH, we sought to examine the effect of the first episode of CVVH on the tissue factor (extrinsic) pathway of coagulation and thrombin generation. Methods. Twelve critically ill patients were studied prior to the commencement of hemofiltration and at regular intervals thereafter until the filter clotted. Results. Prior to hemofiltration, most patients had increased levels of plasma tissue factor. thrombin-antithrombin (TAT) complexes, and tissue factor pathway inhibitor (TFPI); during hemofiltration, further generation of TAT complexes occurred. Initially, levels of activated factor VII (FVIIa) fell and TFPI increased, but during the course of hemofiltration, the levels of TFPI fell and FVIIa increased. Levels of tissue factor increased during CVVH in some patients, but this was not related to the generation of FVIIa. Conclusions. These data indicate that activation of FVII occurred during CVVH, which was related to levels of TFPI, but not tissue factor, and was coincidental to thrombin generation.
引用
收藏
页码:1568 / 1574
页数:7
相关论文
共 39 条
  • [1] STUDY OF THE BALANCE BETWEEN COAGULATION AND FIBRINOLYSIS IN DISSEMINATED INTRAVASCULAR COAGULATION USING MOLECULAR MARKERS
    ASAKURA, H
    JOKAJI, H
    SAITO, M
    UOTANI, C
    KUMABASHIRI, I
    MORISHITA, E
    YAMAZAKI, M
    AOSHIMA, K
    MATSUDA, T
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (05) : 829 - 832
  • [2] THE QUANTITATIVE ASSOCIATION OF PLASMA ENDOTOXIN, ANTITHROMBIN, PROTEIN-C, EXTRINSIC PATHWAY INHIBITOR AND FIBRINOPEPTIDE-A IN SYSTEMIC MENINGOCOCCAL DISEASE
    BRANDTZAEG, P
    SANDSET, PM
    JOO, GB
    OVSTEBO, R
    ABILDGAARD, U
    KIERULF, P
    [J]. THROMBOSIS RESEARCH, 1989, 55 (04) : 459 - 470
  • [3] THE EFFECT OF 2-DOMAIN TISSUE FACTOR PATHWAY INHIBITOR ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN RABBITS
    BREGENGARD, C
    NORDFANG, O
    WILDGOOSE, P
    SVENDSEN, O
    HEDNER, U
    DINESS, V
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) : 699 - 706
  • [4] Endothelial dysfunction in critically ill patients: the effect of haemofiltration
    Cardigan, R
    McGloin, H
    Mackie, I
    Machin, S
    Singer, M
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (12) : 1264 - 1271
  • [5] The effect of heparin and its neutralisation on functional assays for factor VIIa, factor VII and TFPI
    Cardigan, RA
    Mackie, IJ
    Machin, SJ
    [J]. THROMBOSIS RESEARCH, 1996, 84 (04) : 237 - 242
  • [6] CARR C, 1994, CIRC SHOCK, V44, P126
  • [7] THE ROLE OF TISSUE FACTOR IN THE PRODUCTION OF THROMBIN
    CARSON, SD
    BROZNA, JP
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (02) : 281 - 292
  • [8] Tissue factor pathway inhibitor (TFPI) activity in uremic patients during hemodialysis
    Cella, G
    Vertolli, U
    Naso, A
    Vianello, A
    Rampin, E
    Sbarai, A
    Boeri, G
    Strauss, WE
    [J]. THROMBOSIS RESEARCH, 1996, 81 (06) : 671 - 677
  • [9] Edmunds L H Jr, 1995, Adv Card Surg, V6, P131
  • [10] THE CLINICAL-VALUE OF TISSUE FACTOR ASSAYS
    FRANCIS, JL
    CARVALHO, M
    FRANCIS, DA
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 : S37 - S44